Skip to main content

Afinitor Everolimus Copay Assistance Program

Novartis Pharmaceuticals

OpenVerified·Apr 24, 2026

This program, facilitated by QuickRx, offers copay assistance for the medication Afinitor (everolimus) to reduce out-of-pocket costs for eligible patients. It coordinates access to manufacturer copay cards for commercially insured patients and patient assistance programs, including foundation grants, for Medicare, Medicaid, and uninsured patients, aiming for $0 patient cost.

Covers
financial assistance
Enrollment cycle
rolling

Apply

Application goes directly to Novartis Pharmaceuticals. RxCopays does not receive compensation.

Go to application →

Status source

Apply for Afinitor or Zortress (Everolimus) Copay Assistance